LORATADINE AND PSEUDOEPHEDRINE SULFATE

LORATADINE AND PSEUDOEPHEDRINE SULFATE was reported 7924 times

LORATADINE AND PSEUDOEPHEDRINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOFOLLICULITIS BARBAE 3 0.1250
1 DRUG EFFECT DELAYED 82 0.0181
2 MOUTH CYST 3 0.0160
3 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 6 0.0137
4 AMPHETAMINES POSITIVE 10 0.0134
5 ILIOTIBIAL BAND SYNDROME 3 0.0133
6 PARANASAL SINUS HYPOSECRETION 3 0.0120
7 ALLERGY TO PLANTS 4 0.0088
8 SINUS POLYP 5 0.0087
9 DRUG EFFECT DECREASED 454 0.0084
10 FEELING JITTERY 149 0.0078
11 CAROTID BRUIT 3 0.0078
12 BRONCHITIS ACUTE 3 0.0075
13 CORONARY ARTERY ATHEROSCLEROSIS 3 0.0071
14 BUNION 5 0.0070
15 FOREIGN BODY TRAUMA 5 0.0068
16 NASAL DRYNESS 38 0.0061
17 ACTINOMYCOSIS 5 0.0052
18 AORTIC CALCIFICATION 3 0.0052
19 EXPIRED DRUG ADMINISTERED 25 0.0050
20 INTERVERTEBRAL DISC SPACE NARROWING 4 0.0050
21 MITRAL VALVE STENOSIS 3 0.0045
22 POOR QUALITY SLEEP 95 0.0044
23 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 30 0.0044
24 FEELING OF RELAXATION 3 0.0044
25 PAINFUL DEFAECATION 3 0.0043
26 GALLBLADDER INJURY 8 0.0041
27 OTITIS MEDIA ACUTE 3 0.0041
28 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 3 0.0038
29 PRODUCT COMMINGLING 4 0.0038
30 ENERGY INCREASED 22 0.0037
31 TONSILLAR DISORDER 4 0.0036
32 BILIARY DYSKINESIA 6 0.0035
33 LUNG HYPERINFLATION 3 0.0035
34 CYSTOCELE 3 0.0035
35 LUMBAR RADICULOPATHY 4 0.0035
36 PRIMARY SEQUESTRUM 3 0.0033
37 EPICONDYLITIS 5 0.0033
38 NASAL PRURITUS 4 0.0032
39 PRODUCT SHAPE ISSUE 3 0.0032
40 HYPERVIGILANCE 3 0.0031
41 NASAL SEPTUM DEVIATION 6 0.0031
42 FOREIGN BODY IN RESPIRATORY TRACT 4 0.0030
43 MITRAL VALVE PROLAPSE 5 0.0030
44 PRODUCT COATING ISSUE 3 0.0029
45 EXTRA DOSE ADMINISTERED 119 0.0029
46 URINE FLOW DECREASED 7 0.0029
47 FRACTURE NONUNION 4 0.0029
48 CERVICAL SPINAL STENOSIS 5 0.0029
49 ACUTE SINUSITIS 5 0.0029
50 DRUG SCREEN FALSE POSITIVE 8 0.0029
51 PRODUCT BLISTER PACKAGING ISSUE 3 0.0029
52 CHRONIC FATIGUE SYNDROME 4 0.0029
53 THERAPEUTIC PRODUCT INEFFECTIVE 11 0.0028
54 CHOLECYSTITIS CHRONIC 19 0.0028
55 DRUG SCREEN POSITIVE 22 0.0028
56 ESSENTIAL HYPERTENSION 5 0.0027
57 INSOMNIA 723 0.0027
58 EXPIRED PRODUCT ADMINISTERED 88 0.0026
59 PARANASAL SINUS DISCOMFORT 10 0.0026
60 CEREBRAL VENTRICLE DILATATION 3 0.0026
61 PSYCHOMOTOR HYPERACTIVITY 43 0.0026
62 LIP ULCERATION 3 0.0026
63 INCORRECT PRODUCT ADMINISTRATION DURATION 54 0.0025
64 DRY THROAT 25 0.0025
65 OTITIS EXTERNA 3 0.0025
66 NERVOUSNESS 127 0.0024
67 THERAPEUTIC RESPONSE UNEXPECTED 108 0.0024
68 LUMBAR SPINAL STENOSIS 7 0.0024
69 OBSTRUCTION GASTRIC 3 0.0023
70 SENSATION OF HEAVINESS 9 0.0023
71 DRY MOUTH 187 0.0023
72 ONYCHOMYCOSIS 10 0.0023
73 LIP EXFOLIATION 3 0.0023
74 NASAL DISORDER 6 0.0023
75 PRODUCT PACKAGE ASSOCIATED INJURY 5 0.0022
76 FOREIGN BODY IN THROAT 7 0.0022
77 DRUG EFFECT INCREASED 7 0.0022
78 DYSURIA 81 0.0022
79 AGORAPHOBIA 3 0.0022
80 LOBAR PNEUMONIA 4 0.0022
81 PULMONARY INFARCTION 5 0.0021
82 DIABETES MELLITUS NON-INSULIN-DEPENDENT 3 0.0021
83 BREATH ODOUR 5 0.0020
84 PRODUCT USE ISSUE 383 0.0020
85 THIRST 36 0.0020
86 SNEEZING 45 0.0020
87 DRUG EFFECT INCOMPLETE 72 0.0020
88 EUPHORIC MOOD 20 0.0020
89 SYNOVIAL CYST 9 0.0019
90 EYE ALLERGY 3 0.0019
91 PRE-EXISTING CONDITION IMPROVED 12 0.0019
92 PRODUCT PACKAGING DIFFICULT TO OPEN 5 0.0019
93 PHYSICAL ASSAULT 4 0.0019
94 OSTEOSCLEROSIS 3 0.0019
95 DILATATION VENTRICULAR 4 0.0019
96 TRICUSPID VALVE INCOMPETENCE 15 0.0019
97 INITIAL INSOMNIA 19 0.0018
98 INCORRECT DOSAGE ADMINISTERED 9 0.0018
99 PARANASAL SINUS HYPERSECRETION 7 0.0018
100 PLEURITIC PAIN 5 0.0018
101 BLOOD CALCIUM ABNORMAL 3 0.0018
102 EPIGASTRIC DISCOMFORT 7 0.0018
103 PLANTAR FASCIITIS 6 0.0018
104 PRODUCT PACKAGING ISSUE 17 0.0018
105 HEPATOCELLULAR DAMAGE 4 0.0018
106 HEPATIC CYST 6 0.0018
107 NASAL DISCOMFORT 14 0.0018
108 ABDOMINAL HERNIA 8 0.0018
109 TACHYPHRENIA 6 0.0017
110 FLAT AFFECT 4 0.0017
111 PALPITATIONS 201 0.0017
112 KYPHOSIS 3 0.0017
113 GLOSSITIS 6 0.0017
114 MITRAL VALVE INCOMPETENCE 19 0.0017
115 JOINT ARTHROPLASTY 3 0.0017
116 BONE LESION 6 0.0017
117 TENSION HEADACHE 7 0.0016
118 HYPERTENSIVE HEART DISEASE 3 0.0016
119 BLOOD IRON INCREASED 3 0.0016
120 PRODUCT SOLUBILITY ABNORMAL 8 0.0016
121 ABDOMINAL ADHESIONS 5 0.0016
122 RHINITIS ALLERGIC 7 0.0016
123 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
124 MOTION SICKNESS 3 0.0016
125 URINARY TRACT DISORDER 7 0.0016
126 SEASONAL ALLERGY 22 0.0016
127 VENTRICULAR DYSFUNCTION 4 0.0015
128 HEART RATE INCREASED 147 0.0015
129 SPINAL COLUMN STENOSIS 7 0.0015
130 SPINAL OSTEOARTHRITIS 13 0.0015
131 SOMNOLENCE 294 0.0015
132 LACRIMATION INCREASED 44 0.0015
133 ATELECTASIS 14 0.0014
134 CAROTID ARTERY STENOSIS 5 0.0014
135 EAR PRURITUS 5 0.0014
136 HANGOVER 5 0.0014
137 CHOLECYSTITIS ACUTE 8 0.0014
138 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
139 UNEVALUABLE EVENT 106 0.0014
140 MIDDLE INSOMNIA 26 0.0014
141 EXPOSED BONE IN JAW 3 0.0014
142 UPPER RESPIRATORY TRACT CONGESTION 4 0.0014
143 PATHOLOGICAL FRACTURE 7 0.0014
144 RHINORRHOEA 88 0.0014
145 MIDDLE EAR EFFUSION 3 0.0014
146 STOMACH DISCOMFORT 7 0.0014
147 PRODUCT LOT NUMBER ISSUE 3 0.0014
148 SINUS HEADACHE 8 0.0013
149 FEELING DRUNK 10 0.0013
150 ACCIDENTAL OVERDOSE 49 0.0013
151 EYE PRURITUS 45 0.0013
152 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
153 FEAR OF DEATH 3 0.0013
154 IRON DEFICIENCY 6 0.0013
155 CHRONIC SINUSITIS 5 0.0013
156 DRUG INEFFECTIVE 1753 0.0013
157 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
158 PHARYNGOLARYNGEAL PAIN 7 0.0013
159 MASTICATION DISORDER 4 0.0013
160 OESOPHAGEAL DISORDER 5 0.0013
161 DIASTOLIC DYSFUNCTION 4 0.0013
162 SCOLIOSIS 8 0.0013
163 TALIPES 4 0.0013
164 PRODUCT PRESCRIBING ISSUE 28 0.0013
165 RESTLESSNESS 47 0.0013
166 LACERATION 12 0.0013
167 PROSTATOMEGALY 5 0.0013
168 THERAPEUTIC RESPONSE CHANGED 8 0.0013
169 PRODUCT TASTE ABNORMAL 17 0.0013
170 CEREBRAL ATROPHY 5 0.0013
171 LACUNAR INFARCTION 3 0.0013
172 INCORRECT DRUG ADMINISTRATION DURATION 35 0.0012
173 HEAD DISCOMFORT 22 0.0012
174 CARDIAC FLUTTER 8 0.0012
175 GALLBLADDER DISORDER 22 0.0012
176 BRONCHITIS CHRONIC 3 0.0012
177 FACET JOINT SYNDROME 4 0.0012
178 DERMAL CYST 3 0.0012
179 CARTILAGE INJURY 3 0.0012
180 PENIS DISORDER 3 0.0012
181 OTITIS MEDIA 4 0.0012
182 ANEURYSM 6 0.0012
183 EXOSTOSIS 11 0.0012
184 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 35 0.0012
185 NASAL CONGESTION 70 0.0012
186 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
187 SINUS CONGESTION 16 0.0012
188 HOSTILITY 3 0.0012
189 PRODUCT LABEL ISSUE 8 0.0012
190 CHOLECYSTITIS 14 0.0012
191 FLANK PAIN 11 0.0012
192 LACTOSE INTOLERANCE 3 0.0012
193 LUNG NEOPLASM 5 0.0012
194 PHARYNGEAL OEDEMA 18 0.0012
195 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
196 CEREBRAL ISCHAEMIA 6 0.0012
197 DIFFICULTY IN WALKING 4 0.0012
198 BURSITIS 14 0.0012
199 TENSION 7 0.0011
200 MULTIPLE ALLERGIES 9 0.0011
201 RESPIRATORY TRACT CONGESTION 18 0.0011
202 GINGIVAL PAIN 9 0.0011
203 COELIAC DISEASE 11 0.0011
204 RHINITIS 9 0.0011
205 BREAST SWELLING 3 0.0011
206 EAR DISCOMFORT 11 0.0011
207 SINUS DISORDER 21 0.0011
208 OESOPHAGEAL STENOSIS 3 0.0011
209 OSTEOPENIA 16 0.0011
210 GINGIVAL DISORDER 4 0.0010
211 CARDIAC MURMUR 9 0.0010
212 PHARMACEUTICAL PRODUCT COMPLAINT 27 0.0010
213 HYPERTONIC BLADDER 3 0.0010
214 TENDONITIS 16 0.0010
215 HYPOVOLAEMIA 6 0.0010
216 ECCHYMOSIS 7 0.0010
217 LOW TURNOVER OSTEOPATHY 4 0.0010
218 CORONARY ARTERY STENOSIS 5 0.0010
219 TRIGGER FINGER 4 0.0010
220 GOITRE 4 0.0010
221 DRUG ABUSER 6 0.0010
222 INCREASED UPPER AIRWAY SECRETION 5 0.0010
223 PHARYNGITIS 12 0.0010
224 EYE DISCHARGE 10 0.0010
225 BLINDNESS TRANSIENT 7 0.0009
226 NON-CARDIAC CHEST PAIN 3 0.0009
227 BLADDER PAIN 3 0.0009
228 AORTIC VALVE INCOMPETENCE 4 0.0009
229 LOOSE TOOTH 3 0.0009
230 ANOREXIA 12 0.0009
231 ABNORMAL SENSATION IN EYE 4 0.0009
232 PRODUCT SIZE ISSUE 5 0.0009
233 CHEILITIS 5 0.0009
234 HERPES SIMPLEX 6 0.0009
235 URINE OUTPUT DECREASED 8 0.0009
236 DIVERTICULUM INTESTINAL 4 0.0009
237 MELANOCYTIC NAEVUS 4 0.0009
238 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50 0.0009
239 GROIN PAIN 8 0.0009
240 FEELING ABNORMAL 217 0.0009
241 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
242 PEPTIC ULCER 3 0.0009
243 OVARIAN CYST 9 0.0009
244 ANOSMIA 13 0.0009
245 BLOOD PRESSURE INCREASED 136 0.0009
246 UPPER RESPIRATORY TRACT INFECTION 41 0.0009
247 IRRITABLE BOWEL SYNDROME 19 0.0009
248 TOOTHACHE 16 0.0009
249 SLUGGISHNESS 9 0.0009
250 SINUSITIS 90 0.0009
251 BRONCHOPNEUMONIA 3 0.0009
252 MICTURITION URGENCY 10 0.0009
253 VISUAL DISTURBANCE 5 0.0009
254 INJURY 61 0.0009
255 MICTURITION DISORDER 3 0.0009
256 POLLAKIURIA 36 0.0009
257 HYPOAESTHESIA ORAL 13 0.0009
258 MASS 12 0.0009
259 ROSACEA 4 0.0009
260 CARPAL TUNNEL SYNDROME 12 0.0009
261 LOGORRHOEA 3 0.0009
262 DIVERTICULUM 6 0.0008
263 RETCHING 18 0.0008
264 MEDICATION RESIDUE PRESENT 4 0.0008
265 PHARYNGITIS STREPTOCOCCAL 9 0.0008
266 HUMERUS FRACTURE 4 0.0008
267 TONGUE DISORDER 6 0.0008
268 CARDIOMEGALY 10 0.0008
269 NASAL POLYPS 4 0.0008
270 MUSCLE STRAIN 7 0.0008
271 CYST 10 0.0008
272 ABNORMAL DREAMS 22 0.0008
273 CHOLELITHIASIS 26 0.0008
274 SLEEP APNOEA SYNDROME 15 0.0008
275 FACIAL PAIN 7 0.0008
276 CLAVICLE FRACTURE 3 0.0008
277 FEMORAL NECK FRACTURE 4 0.0008
278 ROTATOR CUFF SYNDROME 10 0.0008
279 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
280 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
281 PANIC DISORDER 3 0.0008
282 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 55 0.0008
283 FAECES HARD 3 0.0008
284 CHOKING 15 0.0008
285 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
286 INCREASED TENDENCY TO BRUISE 7 0.0008
287 POLYDIPSIA 3 0.0008
288 GRAND MAL CONVULSION 7 0.0008
289 HAEMATOCRIT DECREASED 15 0.0008
290 DIZZINESS 376 0.0008
291 HYPERLIPIDAEMIA 9 0.0008
292 THINKING ABNORMAL 14 0.0008
293 BREAST PAIN 8 0.0007
294 CANDIDIASIS 3 0.0007
295 COMPRESSION FRACTURE 4 0.0007
296 POST-TRAUMATIC STRESS DISORDER 5 0.0007
297 WRONG TECHNIQUE IN DRUG USAGE PROCESS 27 0.0007
298 THERAPEUTIC RESPONSE DECREASED 45 0.0007
299 STRESS FRACTURE 4 0.0007
300 WRONG PRODUCT ADMINISTERED 5 0.0007
301 NO THERAPEUTIC RESPONSE 9 0.0007
302 SPUTUM DISCOLOURED 7 0.0007
303 COLD SWEAT 13 0.0007
304 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
305 TOOTH FRACTURE 8 0.0007
306 HYPERKERATOSIS 4 0.0007
307 SINUS BRADYCARDIA 7 0.0007
308 DEEP VEIN THROMBOSIS 47 0.0007
309 LYMPHOEDEMA 5 0.0007
310 SLEEP DISORDER 51 0.0007
311 NECROSIS 4 0.0007
312 FORMICATION 5 0.0007
313 TINNITUS 33 0.0007
314 HEART RATE ABNORMAL 4 0.0007
315 ATRIAL SEPTAL DEFECT 6 0.0007
316 RESTLESS LEGS SYNDROME 13 0.0007
317 ANGIOPATHY 4 0.0007
318 THROAT IRRITATION 32 0.0007
319 MUSCULOSKELETAL CHEST PAIN 11 0.0007
320 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
321 POOR PERIPHERAL CIRCULATION 3 0.0007
322 METASTATIC NEOPLASM 3 0.0007
323 PRURITUS GENERALISED 15 0.0007
324 CORONARY ARTERY DISEASE 21 0.0007
325 MOUTH SWELLING 4 0.0007
326 PANIC REACTION 5 0.0007
327 VISUAL FIELD DEFECT 5 0.0007
328 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
329 CHAPPED LIPS 3 0.0007
330 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
331 OSTEOARTHRITIS 29 0.0007
332 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 23 0.0007
333 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
334 ARTHROPOD BITE 5 0.0007
335 VENTRICULAR EXTRASYSTOLES 7 0.0007
336 PLEURISY 4 0.0007
337 PROTHROMBIN TIME PROLONGED 4 0.0007
338 HAEMORRHOIDS 13 0.0007
339 IRRITABILITY 40 0.0007
340 LIP DRY 6 0.0007
341 TENDON PAIN 5 0.0007
342 URINARY RETENTION 22 0.0007
343 PANIC ATTACK 24 0.0007
344 AGITATION 48 0.0007
345 BOWEL MOVEMENT IRREGULARITY 5 0.0007
346 RENAL FAILURE CHRONIC 5 0.0006
347 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
348 DISTURBANCE IN ATTENTION 35 0.0006
349 FOOD ALLERGY 5 0.0006
350 HYPERHIDROSIS 83 0.0006
351 MULTIPLE MYELOMA 3 0.0006
352 ANXIETY 182 0.0006
353 PHOTOPHOBIA 12 0.0006
354 PRODUCT USE COMPLAINT 10 0.0006
355 HYPERSENSITIVITY 117 0.0006
356 SWELLING FACE 41 0.0006
357 TOOTH DISORDER 14 0.0006
358 EPISTAXIS 47 0.0006
359 ANGINA PECTORIS 18 0.0006
360 SCREAMING 4 0.0006
361 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
362 DRUG PRESCRIBING ERROR 12 0.0006
363 FAECAL INCONTINENCE 3 0.0006
364 HYPERCHOLESTEROLAEMIA 6 0.0006
365 ENTEROCOCCAL INFECTION 3 0.0006
366 HEPATITIS ACUTE 4 0.0006
367 ANGINA UNSTABLE 4 0.0006
368 VITAMIN D DEFICIENCY 6 0.0006
369 HORMONE LEVEL ABNORMAL 3 0.0006
370 INFLAMMATORY BOWEL DISEASE 6 0.0006
371 PANCREATIC DISORDER 3 0.0006
372 ORAL CANDIDIASIS 8 0.0006
373 PRODUCT FORMULATION ISSUE 4 0.0006
374 BLADDER DISORDER 6 0.0006
375 THERAPEUTIC RESPONSE SHORTENED 20 0.0006
376 DERMATITIS EXFOLIATIVE 3 0.0006
377 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
378 FEAR 16 0.0006
379 COLITIS ISCHAEMIC 4 0.0006
380 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
381 ANGER 20 0.0006
382 DYSLIPIDAEMIA 3 0.0006
383 HEPATIC STEATOSIS 11 0.0006
384 TOOTH ABSCESS 6 0.0006
385 SCAR 10 0.0006
386 GASTROOESOPHAGEAL REFLUX DISEASE 47 0.0006
387 CROHN'S DISEASE 4 0.0006
388 PERIPHERAL COLDNESS 8 0.0006
389 TEMPERATURE INTOLERANCE 6 0.0006
390 GLOSSODYNIA 13 0.0006
391 PERIORBITAL OEDEMA 3 0.0006
392 NOCTURIA 7 0.0006
393 APLASTIC ANAEMIA 3 0.0006
394 APHONIA 8 0.0006
395 EXTRASYSTOLES 4 0.0006
396 LIP SWELLING 19 0.0006
397 GASTRITIS 15 0.0006
398 HYPERCALCAEMIA 7 0.0006
399 CHEST PAIN 105 0.0006
400 RENAL PAIN 6 0.0006
401 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
402 SCIATICA 9 0.0006
403 EYE SWELLING 21 0.0006
404 MUSCLE TWITCHING 13 0.0006
405 CONVULSION 32 0.0006
406 CHEST DISCOMFORT 57 0.0006
407 PRODUCT RESIDUE PRESENT 3 0.0006
408 BRUXISM 3 0.0006
409 DISORIENTATION 22 0.0006
410 OROPHARYNGEAL DISCOMFORT 5 0.0006
411 BIPOLAR DISORDER 6 0.0006
412 DYSGEUSIA 41 0.0006
413 BACK INJURY 6 0.0006
414 EMOTIONAL DISORDER 17 0.0006
415 BONE DISORDER 10 0.0005
416 TREMOR 91 0.0005
417 ASTHENOPIA 3 0.0005
418 ORAL DISORDER 4 0.0005
419 PROSTATIC DISORDER 3 0.0005
420 DENTAL CARIES 6 0.0005
421 IRON DEFICIENCY ANAEMIA 5 0.0005
422 CEREBRAL DISORDER 4 0.0005
423 HIATUS HERNIA 7 0.0005
424 PERSONALITY CHANGE 5 0.0005
425 PULMONARY EMBOLISM 51 0.0005
426 NEPHROPATHY 5 0.0005
427 RASH PAPULAR 12 0.0005
428 BLOOD CALCIUM DECREASED 6 0.0005
429 ANHEDONIA 14 0.0005
430 PAROSMIA 4 0.0005
431 ABNORMAL BEHAVIOUR 21 0.0005
432 PAIN IN JAW 15 0.0005
433 PERONEAL NERVE PALSY 3 0.0005
434 GENERALISED ERYTHEMA 3 0.0005
435 BRONCHITIS 39 0.0005
436 CARDIAC VALVE DISEASE 3 0.0005
437 EXERCISE TOLERANCE DECREASED 3 0.0005
438 NIGHTMARE 18 0.0005
439 AFFECT LABILITY 5 0.0005
440 OROPHARYNGEAL PAIN 48 0.0005
441 THROAT TIGHTNESS 14 0.0005
442 CONGENITAL ANOMALY 4 0.0005
443 EYELID OEDEMA 6 0.0005
444 LOCAL SWELLING 9 0.0005
445 BLOOD CHOLESTEROL INCREASED 24 0.0005
446 IMPAIRED WORK ABILITY 11 0.0005
447 MOOD ALTERED 14 0.0005
448 ASTHMA 58 0.0005
449 SWOLLEN TONGUE 16 0.0005
450 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
451 SEXUAL DYSFUNCTION 6 0.0005
452 HYPOAESTHESIA 76 0.0005
453 FURUNCLE 4 0.0005
454 BLOOD ALBUMIN DECREASED 4 0.0005
455 ORAL DISCOMFORT 7 0.0005
456 RENAL CYST 4 0.0005
457 ATRIAL FLUTTER 4 0.0005
458 SALIVARY HYPERSECRETION 5 0.0005
459 BLOOD DISORDER 4 0.0005
460 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
461 LEUKOCYTOSIS 9 0.0005
462 LOCALISED INFECTION 12 0.0005
463 PRODUCT PHYSICAL ISSUE 10 0.0005
464 CRYING 18 0.0005
465 FIBROMYALGIA 12 0.0005
466 FEELING HOT 30 0.0005
467 DRUG ADMINISTRATION ERROR 15 0.0005
468 POLYURIA 4 0.0005
469 PIGMENTATION DISORDER 3 0.0005
470 PARAESTHESIA ORAL 7 0.0005
471 CONJUNCTIVITIS 9 0.0005
472 OSTEONECROSIS OF JAW 12 0.0005
473 PRODUCT USE IN UNAPPROVED INDICATION 120 0.0005
474 PETECHIAE 5 0.0005
475 PRODUCT ODOUR ABNORMAL 5 0.0005
476 CATARACT 28 0.0005
477 CONSTIPATION 102 0.0005
478 GASTRIC DISORDER 16 0.0005
479 MUSCULOSKELETAL DISCOMFORT 8 0.0005
480 ANURIA 4 0.0005
481 POOR QUALITY DRUG ADMINISTERED 3 0.0005
482 INCOHERENT 3 0.0005
483 MIGRAINE 44 0.0005
484 EYE PAIN 26 0.0005
485 CHILLS 54 0.0005
486 SKIN LACERATION 5 0.0005
487 OEDEMA PERIPHERAL 56 0.0005
488 VERTIGO 28 0.0005
489 FLATULENCE 26 0.0005
490 POLYP 3 0.0005
491 DYSPEPSIA 45 0.0005
492 ABDOMINAL DISCOMFORT 76 0.0005
493 LUNG INFILTRATION 4 0.0005
494 EAR INFECTION 12 0.0005
495 HEADACHE 282 0.0004
496 EYE HAEMORRHAGE 6 0.0004
497 WRONG DRUG ADMINISTERED 4 0.0004
498 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
499 GASTROINTESTINAL INFECTION 4 0.0004
500 OCULAR DISCOMFORT 5 0.0004
501 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
502 DEPRESSION 101 0.0004
503 CHROMATURIA 10 0.0004
504 EYE INFECTION 5 0.0004
505 OCULAR HYPERAEMIA 21 0.0004
506 OBESITY 7 0.0004
507 URINARY INCONTINENCE 13 0.0004
508 ABSCESS 7 0.0004
509 CHOLECYSTECTOMY 5 0.0004
510 RIB FRACTURE 9 0.0004
511 RESPIRATION ABNORMAL 3 0.0004
512 JOINT EFFUSION 3 0.0004
513 DEPRESSED MOOD 23 0.0004
514 HAIR GROWTH ABNORMAL 3 0.0004
515 NERVE COMPRESSION 4 0.0004
516 LARGE INTESTINE POLYP 3 0.0004
517 MUSCLE TIGHTNESS 7 0.0004
518 COUGH 121 0.0004
519 VISION BLURRED 59 0.0004
520 VASCULITIS 5 0.0004
521 DEFORMITY 4 0.0004
522 DYSPHONIA 25 0.0004
523 SUICIDAL IDEATION 39 0.0004
524 ARRHYTHMIA 20 0.0004
525 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 22 0.0004
526 WHEEZING 25 0.0004
527 BACTERAEMIA 5 0.0004
528 VIRAL INFECTION 14 0.0004
529 METASTASIS 3 0.0004
530 AGGRESSION 21 0.0004
531 PRODUCTIVE COUGH 20 0.0004
532 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
533 INCREASED APPETITE 8 0.0004
534 HYPERSOMNIA 12 0.0004
535 OVERDOSE 90 0.0004
536 HERNIA 8 0.0004
537 DIZZINESS POSTURAL 4 0.0004
538 DRUG EXPOSURE DURING PREGNANCY 14 0.0004
539 PRESYNCOPE 10 0.0004
540 MAJOR DEPRESSION 3 0.0004
541 ORAL HERPES 8 0.0004
542 MOUTH HAEMORRHAGE 3 0.0004
543 ROAD TRAFFIC ACCIDENT 17 0.0004
544 DYSPNOEA 230 0.0004
545 PARANOIA 7 0.0004
546 SKIN HAEMORRHAGE 6 0.0004
547 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 82 0.0004
548 DISABILITY 8 0.0004
549 LIGAMENT SPRAIN 4 0.0004
550 ABDOMINAL PAIN UPPER 83 0.0004
551 ORAL PAIN 9 0.0004
552 AGEUSIA 10 0.0004
553 PARAESTHESIA 63 0.0004
554 SYNCOPE 40 0.0004
555 AMNESIA 26 0.0004
556 INCORRECT DOSE ADMINISTERED 91 0.0004
557 HEART RATE IRREGULAR 9 0.0004
558 DIVERTICULITIS 11 0.0004
559 ECONOMIC PROBLEM 6 0.0004
560 AORTIC ANEURYSM 3 0.0004
561 MOTOR DYSFUNCTION 4 0.0004
562 HYPERTENSION 83 0.0004
563 GOUT 7 0.0004
564 ERECTILE DYSFUNCTION 10 0.0004
565 THYROID DISORDER 6 0.0004
566 OSTEOPOROSIS 16 0.0004
567 CONCUSSION 3 0.0004
568 OSTEOMYELITIS 7 0.0004
569 HALLUCINATION 29 0.0004
570 HAEMORRHAGIC STROKE 3 0.0004
571 PULMONARY HYPERTENSION 8 0.0004
572 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
573 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
574 AFFECTIVE DISORDER 3 0.0004
575 CONDITION AGGRAVATED 116 0.0004
576 ANKYLOSING SPONDYLITIS 5 0.0004
577 HALLUCINATION, AUDITORY 6 0.0004
578 DYSMENORRHOEA 5 0.0004
579 ADVERSE REACTION 5 0.0004
580 DISCOMFORT 23 0.0004
581 FLUSHING 38 0.0004
582 HEREDITARY ANGIOEDEMA 4 0.0004
583 NIGHT SWEATS 12 0.0004
584 SKIN CANCER 8 0.0004
585 BALANCE DISORDER 32 0.0004
586 UNDERDOSE 27 0.0004
587 BLOOD POTASSIUM INCREASED 6 0.0004
588 FOOT FRACTURE 7 0.0004
589 BLOOD URINE PRESENT 7 0.0004
590 PALLOR 10 0.0004
591 ADVERSE DRUG REACTION 33 0.0004
592 PULMONARY THROMBOSIS 4 0.0004
593 GINGIVAL BLEEDING 5 0.0004
594 HYPERAESTHESIA 3 0.0004
595 LETHARGY 21 0.0004
596 ESCHERICHIA INFECTION 3 0.0004
597 POST PROCEDURAL COMPLICATION 7 0.0004
598 LOWER LIMB FRACTURE 7 0.0004
599 STAPHYLOCOCCAL INFECTION 12 0.0004
600 GASTROINTESTINAL PAIN 4 0.0004
601 GLAUCOMA 7 0.0004
602 EMOTIONAL DISTRESS 44 0.0004
603 PHOTOSENSITIVITY REACTION 6 0.0004
604 MENSTRUAL DISORDER 3 0.0004
605 ERUCTATION 7 0.0004
606 FOOT DEFORMITY 4 0.0004
607 HEMIPLEGIA 3 0.0004
608 DRY EYE 18 0.0004
609 EAR PAIN 7 0.0004
610 EOSINOPHIL COUNT INCREASED 3 0.0004
611 NERVE INJURY 4 0.0004
612 CELLULITIS 18 0.0004
613 SKIN INFECTION 4 0.0004
614 FEMUR FRACTURE 11 0.0004
615 MUSCLE SPASMS 65 0.0004
616 NAUSEA 279 0.0004
617 SINUS TACHYCARDIA 5 0.0004
618 IMPAIRED DRIVING ABILITY 4 0.0004
619 LOSS OF CONSCIOUSNESS 45 0.0004
620 DERMATITIS CONTACT 4 0.0004
621 PREGNANCY 7 0.0003
622 EYE IRRITATION 20 0.0003
623 DIPLOPIA 9 0.0003
624 CYSTITIS 11 0.0003
625 MOOD SWINGS 11 0.0003
626 INJECTION SITE HAEMATOMA 5 0.0003
627 HYPOTHYROIDISM 11 0.0003
628 POST PROCEDURAL HAEMORRHAGE 4 0.0003
629 GASTROENTERITIS 5 0.0003
630 NECK PAIN 19 0.0003
631 PSYCHOTIC DISORDER 10 0.0003
632 RESPIRATORY RATE INCREASED 3 0.0003
633 DEHYDRATION 45 0.0003
634 NEUROPATHY PERIPHERAL 32 0.0003
635 MALAISE 147 0.0003
636 MYOSITIS 3 0.0003
637 DERMATITIS 7 0.0003
638 ASTHENIA 125 0.0003
639 MOUTH ULCERATION 7 0.0003
640 HALLUCINATION, VISUAL 7 0.0003
641 SWELLING 31 0.0003
642 MENTAL IMPAIRMENT 8 0.0003
643 NEURALGIA 8 0.0003
644 EATING DISORDER 7 0.0003
645 FATIGUE 255 0.0003
646 DECREASED APPETITE 76 0.0003
647 DRUG DISPENSING ERROR 5 0.0003
648 SKIN DISCOLOURATION 15 0.0003
649 ANAPHYLACTIC REACTION 18 0.0003
650 ECZEMA 17 0.0003
651 CARDIAC FAILURE CONGESTIVE 26 0.0003
652 DIARRHOEA HAEMORRHAGIC 3 0.0003
653 SECRETION DISCHARGE 4 0.0003
654 ARTERIOSCLEROSIS 3 0.0003
655 DYSPNOEA EXERTIONAL 12 0.0003
656 COLITIS 12 0.0003
657 TACHYCARDIA 28 0.0003
658 RASH MACULAR 11 0.0003
659 FLUID RETENTION 16 0.0003
660 OEDEMA 17 0.0003
661 INTRAOCULAR PRESSURE INCREASED 4 0.0003
662 PULMONARY FIBROSIS 6 0.0003
663 SENSORY DISTURBANCE 5 0.0003
664 RASH GENERALISED 8 0.0003
665 HAEMATOMA 8 0.0003
666 INJECTION SITE INDURATION 4 0.0003
667 RENAL FAILURE ACUTE 13 0.0003
668 DEAFNESS 8 0.0003
669 MEDICATION ERROR 17 0.0003
670 BACK PAIN 71 0.0003
671 DYSPHAGIA 29 0.0003
672 SEDATION 8 0.0003
673 SPEECH DISORDER 16 0.0003
674 HEPATOMEGALY 3 0.0003
675 ACUTE MYOCARDIAL INFARCTION 9 0.0003
676 BODY TEMPERATURE DECREASED 3 0.0003
677 EYE DISORDER 10 0.0003
678 MANIA 5 0.0003
679 TOOTH INFECTION 4 0.0003
680 DIABETES MELLITUS 23 0.0003
681 UPPER LIMB FRACTURE 6 0.0003
682 ABDOMINAL PAIN 70 0.0003
683 RESPIRATORY DISORDER 9 0.0003
684 COAGULOPATHY 5 0.0003
685 WEIGHT INCREASED 67 0.0003
686 BLOOD UREA INCREASED 5 0.0003
687 HEPATIC FAILURE 9 0.0003
688 NASOPHARYNGITIS 55 0.0003
689 QUALITY OF LIFE DECREASED 4 0.0003
690 APHASIA 9 0.0003
691 TYPE 2 DIABETES MELLITUS 10 0.0003
692 HYPOTHERMIA 3 0.0003
693 PAIN IN EXTREMITY 87 0.0003
694 RASH PRURITIC 16 0.0003
695 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
696 BODY TEMPERATURE INCREASED 6 0.0003
697 DRUG TOXICITY 4 0.0003
698 VOMITING 138 0.0003
699 URTICARIA 49 0.0003
700 CONFUSIONAL STATE 47 0.0003
701 HAEMATOCHEZIA 16 0.0003
702 CEREBROVASCULAR ACCIDENT 49 0.0003
703 NERVOUS SYSTEM DISORDER 9 0.0003
704 ATRIAL FIBRILLATION 28 0.0003
705 FEELING COLD 8 0.0003
706 HUNGER 4 0.0003
707 PRODUCT QUALITY ISSUE 39 0.0003
708 COORDINATION ABNORMAL 4 0.0003
709 RASH 125 0.0003
710 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
711 DERMATITIS ATOPIC 15 0.0003
712 INCONTINENCE 3 0.0003
713 NEPHROLITHIASIS 13 0.0003
714 ADVERSE EVENT 26 0.0003
715 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
716 JOINT INJURY 6 0.0003
717 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
718 STOMATITIS 17 0.0003
719 BREAST CANCER METASTATIC 3 0.0003
720 DECREASED ACTIVITY 3 0.0003
721 ABDOMINAL DISTENSION 29 0.0003
722 ABDOMINAL PAIN LOWER 7 0.0003
723 FAECES DISCOLOURED 6 0.0003
724 HYPOKINESIA 4 0.0003
725 OESOPHAGITIS 3 0.0003
726 IMPAIRED HEALING 9 0.0003
727 DISEASE RECURRENCE 13 0.0003
728 THERAPY CESSATION 14 0.0003
729 BURNING SENSATION 19 0.0003
730 PAIN 166 0.0003
731 SKIN DISORDER 9 0.0003
732 PULMONARY MASS 4 0.0003
733 ARTHRITIS 21 0.0003
734 REBOUND EFFECT 3 0.0003
735 MYALGIA 45 0.0003
736 MYOCARDIAL ISCHAEMIA 3 0.0003
737 HIP ARTHROPLASTY 4 0.0003
738 DEVICE RELATED INFECTION 4 0.0003
739 CONTUSION 25 0.0003
740 RENAL DISORDER 12 0.0003
741 DELUSION 4 0.0003
742 COGNITIVE DISORDER 12 0.0003
743 BONE PAIN 15 0.0003
744 SKIN FISSURES 5 0.0003
745 SKIN LESION 7 0.0003
746 MUSCULAR WEAKNESS 29 0.0003
747 PRURITUS 98 0.0003
748 ERYTHEMA 52 0.0003
749 ATAXIA 3 0.0003
750 URINARY TRACT INFECTION 43 0.0003
751 MENTAL STATUS CHANGES 7 0.0003
752 BLOOD PRESSURE ABNORMAL 5 0.0003
753 MUSCULOSKELETAL STIFFNESS 22 0.0003
754 HAEMOPTYSIS 7 0.0003
755 DRUG WITHDRAWAL SYNDROME 22 0.0003
756 ARTHRALGIA 103 0.0002
757 PLEURAL EFFUSION 15 0.0002
758 COLITIS ULCERATIVE 11 0.0002
759 METASTASES TO BONE 4 0.0002
760 WEIGHT DECREASED 68 0.0002
761 PRODUCT SUBSTITUTION ISSUE 14 0.0002
762 ILEUS 3 0.0002
763 LIVER FUNCTION TEST ABNORMAL 7 0.0002
764 INTENTIONAL DRUG MISUSE 5 0.0002
765 HOT FLUSH 18 0.0002
766 DIARRHOEA 153 0.0002
767 MUSCLE ATROPHY 3 0.0002
768 HEMIPARESIS 4 0.0002
769 CARDIAC DISORDER 22 0.0002
770 HEPATIC ENZYME INCREASED 16 0.0002
771 METRORRHAGIA 4 0.0002
772 GASTROINTESTINAL DISORDER 21 0.0002
773 ARTHROPATHY 13 0.0002
774 INJECTION SITE ERYTHEMA 29 0.0002
775 DRUG RESISTANCE 6 0.0002
776 BLOOD POTASSIUM DECREASED 7 0.0002
777 RECTAL HAEMORRHAGE 10 0.0002
778 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
779 PLATELET COUNT INCREASED 3 0.0002
780 RASH ERYTHEMATOUS 11 0.0002
781 PRODUCT DISPENSING ERROR 5 0.0002
782 JOINT STIFFNESS 6 0.0002
783 AMENORRHOEA 4 0.0002
784 IMMUNE SYSTEM DISORDER 3 0.0002
785 PULMONARY CONGESTION 3 0.0002
786 HYPOXIA 8 0.0002
787 PANCREATITIS 12 0.0002
788 LIMB DISCOMFORT 7 0.0002
789 INJECTION SITE BRUISING 18 0.0002
790 DRY SKIN 30 0.0002
791 GAIT DISTURBANCE 43 0.0002
792 PULMONARY OEDEMA 10 0.0002
793 JAUNDICE 6 0.0002
794 GASTROENTERITIS VIRAL 4 0.0002
795 DYSKINESIA 9 0.0002
796 PNEUMONITIS 6 0.0002
797 IMPAIRED GASTRIC EMPTYING 3 0.0002
798 MYOCARDIAL INFARCTION 38 0.0002
799 RESPIRATORY DISTRESS 6 0.0002
800 PERICARDIAL EFFUSION 5 0.0002
801 SUICIDE ATTEMPT 13 0.0002
802 BLOOD TEST ABNORMAL 3 0.0002
803 OSTEONECROSIS 7 0.0002
804 HEPATIC CIRRHOSIS 4 0.0002
805 DYSARTHRIA 8 0.0002
806 BLOOD PRESSURE DECREASED 14 0.0002
807 GASTRIC ULCER 4 0.0002
808 BRONCHOSPASM 3 0.0002
809 OFF LABEL USE 184 0.0002
810 FUNGAL INFECTION 7 0.0002
811 EXPOSURE DURING PREGNANCY 13 0.0002
812 FALL 69 0.0002
813 JOINT SWELLING 25 0.0002
814 DRUG INTOLERANCE 20 0.0002
815 MENTAL DISORDER 9 0.0002
816 HYPOGLYCAEMIA 10 0.0002
817 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
818 ILLNESS 21 0.0002
819 ABASIA 5 0.0002
820 PYREXIA 70 0.0002
821 IMMUNODEFICIENCY 3 0.0002
822 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
823 SPINAL FRACTURE 4 0.0002
824 PNEUMONIA 64 0.0002
825 INFLUENZA 22 0.0002
826 FEEDING DISORDER 4 0.0002
827 DEVICE FAILURE 3 0.0002
828 INSURANCE ISSUE 3 0.0002
829 INFLUENZA LIKE ILLNESS 16 0.0002
830 ANAPHYLACTIC SHOCK 5 0.0002
831 ANKLE FRACTURE 3 0.0002
832 INFLAMMATION 10 0.0002
833 EJECTION FRACTION DECREASED 3 0.0002
834 TOOTH LOSS 4 0.0002
835 BASAL CELL CARCINOMA 3 0.0002
836 RESPIRATORY FAILURE 14 0.0002
837 HAEMORRHAGE 20 0.0002
838 MUSCULOSKELETAL PAIN 10 0.0002
839 CYANOSIS 3 0.0002
840 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
841 PNEUMOTHORAX 3 0.0002
842 MENSTRUATION IRREGULAR 5 0.0002
843 BLOOD GLUCOSE INCREASED 35 0.0002
844 FREQUENT BOWEL MOVEMENTS 5 0.0002
845 LIMB INJURY 5 0.0002
846 ANAEMIA 35 0.0002
847 DRUG INTERACTION 29 0.0002
848 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
849 VISUAL ACUITY REDUCED 6 0.0002
850 PANCYTOPENIA 10 0.0002
851 OXYGEN SATURATION DECREASED 10 0.0002
852 HAEMOGLOBIN DECREASED 18 0.0002
853 RED BLOOD CELL COUNT DECREASED 5 0.0002
854 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
855 SKIN IRRITATION 8 0.0002
856 DRUG DEPENDENCE 28 0.0002
857 THROMBOSIS 14 0.0002
858 HYPOKALAEMIA 8 0.0002
859 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
860 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
861 INTENTIONAL OVERDOSE 11 0.0002
862 NEUROTOXICITY 3 0.0002
863 EOSINOPHILIA 3 0.0002
864 METASTASES TO LIVER 3 0.0002
865 LYMPHOCYTE COUNT DECREASED 3 0.0002
866 INJECTION SITE SWELLING 13 0.0002
867 CARDIAC ARREST 14 0.0002
868 LYMPHADENOPATHY 6 0.0002
869 VISUAL IMPAIRMENT 21 0.0002
870 COMA 8 0.0002
871 BLOOD GLUCOSE DECREASED 8 0.0002
872 SKIN EXFOLIATION 14 0.0002
873 INJECTION SITE PRURITUS 11 0.0002
874 INJECTION SITE HAEMORRHAGE 13 0.0002
875 VAGINAL HAEMORRHAGE 7 0.0002
876 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
877 MEMORY IMPAIRMENT 22 0.0002
878 INJECTION SITE PAIN 49 0.0002
879 INTESTINAL OBSTRUCTION 6 0.0002
880 BLOOD SODIUM DECREASED 3 0.0002
881 INFECTION 23 0.0002
882 HYPOCALCAEMIA 3 0.0002
883 PROTEINURIA 3 0.0002
884 CARDIOVASCULAR DISORDER 4 0.0002
885 DRUG DOSE OMISSION 26 0.0002
886 HEPATITIS 4 0.0002
887 HIP FRACTURE 5 0.0002
888 UNRESPONSIVE TO STIMULI 4 0.0002
889 SKIN ULCER 4 0.0002
890 PLASMA CELL MYELOMA 6 0.0002
891 MENORRHAGIA 3 0.0002
892 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
893 RENAL FAILURE 20 0.0002
894 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
895 BLOOD BILIRUBIN INCREASED 4 0.0001
896 BLINDNESS 6 0.0001
897 INJECTION SITE REACTION 10 0.0001
898 RESPIRATORY ARREST 4 0.0001
899 PROCEDURAL PAIN 4 0.0001
900 LUNG DISORDER 7 0.0001
901 ALOPECIA 28 0.0001
902 HYPERKALAEMIA 5 0.0001
903 TARDIVE DYSKINESIA 4 0.0001
904 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
905 RHEUMATOID ARTHRITIS 16 0.0001
906 HYPOACUSIS 6 0.0001
907 HYPERGLYCAEMIA 5 0.0001
908 DYSSTASIA 4 0.0001
909 SURGERY 8 0.0001
910 FEBRILE NEUTROPENIA 9 0.0001
911 RASH MACULO-PAPULAR 3 0.0001
912 APPLICATION SITE PRURITUS 3 0.0001
913 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
914 INJECTION SITE RASH 4 0.0001
915 TREATMENT NONCOMPLIANCE 7 0.0001
916 HEAD INJURY 4 0.0001
917 PRODUCT PRESCRIBING ERROR 3 0.0001
918 INTENTIONAL PRODUCT MISUSE 11 0.0001
919 SEPSIS 14 0.0001
920 MULTIPLE SCLEROSIS 6 0.0001
921 BLOOD PRESSURE FLUCTUATION 3 0.0001
922 HYPONATRAEMIA 7 0.0001
923 DEVICE BREAKAGE 5 0.0001
924 CEREBRAL INFARCTION 3 0.0001
925 ENCEPHALOPATHY 3 0.0001
926 PLATELET COUNT DECREASED 13 0.0001
927 EXTRAPYRAMIDAL DISORDER 3 0.0001
928 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
929 WITHDRAWAL SYNDROME 5 0.0001
930 RENAL IMPAIRMENT 10 0.0001
931 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
932 DELIRIUM 4 0.0001
933 RESPIRATORY TRACT INFECTION 3 0.0001
934 MUCOSAL INFLAMMATION 3 0.0001
935 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
936 COVID-19 20 0.0001
937 ANGIOEDEMA 5 0.0001
938 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
939 BREAST CANCER FEMALE 3 0.0001
940 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
941 SKIN BURNING SENSATION 8 0.0001
942 PAIN OF SKIN 3 0.0001
943 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
944 ACNE 8 0.0001
945 INTENTIONAL DOSE OMISSION 3 0.0001
946 HYPOTENSION 21 0.0001
947 HERPES ZOSTER 6 0.0001
948 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
949 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
950 PANCREATIC CARCINOMA 3 0.0001
951 INTERSTITIAL LUNG DISEASE 5 0.0001
952 LABORATORY TEST ABNORMAL 3 0.0001
953 DEVICE MALFUNCTION 7 0.0001
954 PRODUCT DOSE OMISSION ISSUE 29 0.0001
955 PSORIATIC ARTHROPATHY 4 0.0001
956 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
957 NEUTROPENIA 13 0.0001
958 MOVEMENT DISORDER 3 0.0001
959 CHRONIC KIDNEY DISEASE 7 0.0001
960 INFUSION RELATED REACTION 6 0.0001
961 LIVER DISORDER 4 0.0001
962 THROMBOCYTOPENIA 10 0.0001
963 BLISTER 5 0.0001
964 HAEMATURIA 3 0.0001
965 SEIZURE 10 0.0001
966 HEART RATE DECREASED 3 0.0001
967 PRODUCT ADHESION ISSUE 3 0.0001
968 MOBILITY DECREASED 6 0.0001
969 ILL-DEFINED DISORDER 5 0.0001
970 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
971 BLOOD CREATININE INCREASED 5 0.0001
972 BREAST CANCER 7 0.0001
973 NEOPLASM MALIGNANT 5 0.0001
974 ABORTION SPONTANEOUS 3 0.0001
975 LUNG NEOPLASM MALIGNANT 3 0.0001
976 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
977 NO ADVERSE EVENT 13 0.0001
978 CARDIO-RESPIRATORY ARREST 3 0.0001
979 PERIPHERAL SWELLING 11 0.0001
980 PSORIASIS 9 0.0001
981 PRODUCT STORAGE ERROR 6 0.0001
982 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
983 CARDIAC FAILURE 5 0.0001
984 BRADYCARDIA 3 0.0001
985 DEPENDENCE 3 0.0001
986 TOXICITY TO VARIOUS AGENTS 9 0.0001
987 DISEASE PROGRESSION 6 0.0001
988 DEVICE EXPULSION 3 0.0000
989 DEVICE ISSUE 4 0.0000
990 ACUTE KIDNEY INJURY 6 0.0000
991 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
992 DEATH 33 0.0000
993 COMPLETED SUICIDE 3 0.0000
994 HOSPITALISATION 5 0.0000